港股年内4只新股上市首日齐破发

Core Viewpoint - Four newly listed companies on the Hong Kong stock market experienced a collective drop on their first trading day, marking a significant event in the market's recent history [1][2]. Group 1: Market Performance - On December 22, the closing prices of the four companies—Hua Chen Biotech, Ming Kee Hospital, Nanhua Futures, and Impression Da Hong Pao—fell by 29%, 49%, 24%, and 35% respectively on their debut [1]. - This event represents the first instance of four new stocks collectively breaking their issue price on the first day since 2025, with Ming Kee Hospital setting a new record for the largest drop on debut this year [2]. - As of the next trading day, the stocks continued to decline, with Ming Kee Hospital down 48%, Hua Chen Biotech down 42%, Impression Da Hong Pao down 38%, and Nanhua Futures down 23% from their issue prices [3]. Group 2: Market Conditions - The overall performance of the Hong Kong stock market has been under pressure, with the Hang Seng Technology Index dropping nearly 17% since October, and a maximum drawdown of 19% [3]. - The number of IPOs in the Hong Kong market has surged, with 49 new listings in the fourth quarter alone, representing a more than 90% increase from the previous quarter, exacerbating the supply-demand imbalance [3]. Group 3: Company Fundamentals - Hua Chen Biotech, as an innovative pharmaceutical company, has not yet achieved significant revenue, reporting nearly zero income for the first three quarters of 2025 [4]. - Ming Kee Hospital, despite owning multiple hospitals, reported a net loss of 53 million yuan in the first half of 2025, a decrease of nearly 25% year-on-year [4]. - Overall, the first-day drop rate for new IPOs in the Hong Kong market is approximately 29%, with 31 new stocks experiencing a drop this year, a decrease of 7 percentage points compared to 2024 [4]. Group 4: Future Outlook - Nearly half of the 31 new stocks that broke their issue price this year did so in the fourth quarter, raising concerns about a potential wave of IPO failures in 2026 [5]. - By December 22, 2025, 45 new stocks had fallen below their issue price, accounting for over 40% of the total new listings for the year [6]. - Deloitte forecasts that the Hong Kong IPO market will maintain a high frequency in 2026, with an expected 160 new listings and a fundraising target of 300 billion HKD [6]. Group 5: Investment Strategy - Huatai Securities emphasizes the importance of selecting high-quality stocks for new listings, noting that the overall attractiveness of IPOs in Hong Kong has diminished since 2016, with high returns often coming from a small number of high-potential stocks [7].